Cover [Abstract]
Document Type
Amendment Flag
Document Quarterly Report
Document Transition Report
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Entity Common Stock, Shares Outstanding
Condensed Consolidated Balance Sheets
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Carrying amount as of the balance sheet date of research and development tax incentive receivable current. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.
R&D tax credit incentive receivable
Research and Development Tax Incentive Receivable Current
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Assets, Current
Total current assets
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Operating lease right-of-use assets, net
Operating Lease, Right-of-Use Asset
Other Assets, Noncurrent
Restricted cash
The element represents deposits and other assets
Deposits And Other Assets
Deposits and other assets
TOTAL ASSETS
Total Assets
Assets amount
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts Payable, Current
Accounts payable
Accrued Liabilities, Current
Accrued expenses
LitigationReserveCurrent
Litigation accrual
EmployeeRelatedLiabilitiesCurrent
Accrued compensation expense
Lease liability, current portion
Operating Lease, Liability, Current
Liabilities, Current
Total current liabilities
Operating Lease, Liability, Noncurrent
Lease liability, noncurrent portion
TOTAL LIABILITIES
Liabilities
Commitments and contingencies (Note 12)
Commitments and Contingencies
Additional Paid in Capital
Additional paid-in capital
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Equity, Attributable to Parent
Ending balance, value
Beginning balance, value
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities and Equity
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Common stock, par value (in dollars per share)
Common stock, purchase price, per share
Common Stock, No Par Value
Common Stock, Shares Authorized
Common stock, shares authorized
Common stock, shares issued
Common Stock, Shares, Issued
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Beginning balance (in shares)
Ending balance (in shares)
Condensed Consolidated Statements of Operations
Operating expenses:
Research and Development Expense
Research and development, net of grants
General and Administrative Expense
General and administrative, net of grants
Operating Income (Loss)
Loss from operations
Other Operating Income (Expense), Net
Other income, net
Segment net loss
Net loss
Net income attributable to Inter Parfums, Inc (in dollars)
Net Income (Loss) Attributable to Parent
Net loss
Net loss per common share - basic (in dollars per share)
Basic (in dollars per share)
Earnings Per Share, Basic
Net loss per common share - diluted (in dollars per share)
Earnings Per Share, Diluted
Condensed Consolidated Statements of Comprehensive Loss
The element represents other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent 01.
Foreign Currency Translation Adjustments
Foreign currency translation adjustments
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Condensed Consolidated Statements of Stockholders' Equity
Statement [Table]
Equity Components [Axis]
Equity Component [Domain]
Common Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income [Member]
Retained Earnings [Member]
Accumulated Deficit [Member]
Statement [Line Items]
Stock Issued During Period, Shares, Issuance of Common Stock and Warrants in Connection with Securities Purchase Agreement, Net of Issuance Costs
Issuance of common stock and warrants in connection with Securities Purchase Agreement, net of issuance costs (in shares)
The number of shares issued during the period upon issuance of common stock and warrants in connection with securities purchase agreement, net of issuance costs.
Stock-based compensation expense
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Foreign currency translation adjustments
Condensed Consolidated Statements of Cash Flows
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation
Non-cash lease expense
Operating Lease, Right-of-Use Asset, Periodic Reduction
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Employee Related Liabilities
Accrued compensation expenses
Increase (Decrease) in Accrued Liabilities
Accrued expenses
Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment
Purchases of property and equipment
Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities:
The cash inflow from the issuance of common stock and warrants in connection with securities purchase agreement, net of issuance costs during the reporting period.
Issuance of common stock and warrants in connection with the Securities Purchase Agreement, net of issuance costs
Proceeds from Issuance of Common Stock and Warrants in Connection with Securities Purchase Agreement, Net of Issuance Costs
Proceeds from issuance of common stock and warrants in connection with securities purchase agreement, net of issuance costs
The cash outflow to repay principal for insurance premium loan, classified as financing activities.
Repayments of Principal for Insurance Premium Loan Classified as Financing Activities
Payments on insurance premium loan
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Effect of exchange rate changes on cash and cash equivalents
Cash, cash equivalents and restricted cash balance at beginning of period
Cash, cash equivalents and restricted cash balance at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Supplemental Cash Flow Information [Abstract]
Cash paid during the period for:
Income Taxes Paid, Net [Abstract]
Income Taxes Paid, Net
Income taxes
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Non-cash investing and financing activities:
The element represents purchase of property and equipment in accrued expenses.
Purchases of property and equipment in accounts payable and accrued expenses
Purchases of property and equipment in accounts payable and accrued expenses
Organization and Business Operations
Organization and Business Operations
Nature of Operations [Text Block]
Basis of Presentation and Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies [Text Block]
Concentration of Risk
Concentration of Risk [Abstract]
Concentration Risk Disclosure [Text Block]
Concentration of Risk
Fair Value Measurements
Fair Value Measurements
Fair Value Disclosures [Text Block]
Insurance Premium Financing
Insurance Premium Financing
Insurance Premium Financing
Short-Term Debt [Text Block]
Selected Balance Sheet Detail
Selected Balance Sheet Detail
Supplemental Balance Sheet Disclosures [Text Block]
Equity Securities
Equity Securities
Equity [Text Block]
Warrants
Warrants
The element represents warrant disclosure text block.
Warrant Disclosure [Text Block]
Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Stock-Based Compensation
Net Loss Per Share
Net Loss Per Share
Earnings Per Share [Text Block]
Following Table Summarizes Supplemental Balance Sheet Information Related To Companys Operating Leases In Thousands
Following Table Summarizes Maturity Analysis Of Our Lease Liabilities Showing Aggregate Lease Payments As Of March 31 2024 In Thousands Except Weighted Average Data
Right-of-use Assets and Operating Lease Liabilities
Right-of-use Assets and Operating Lease Liabilities
Lessee, Operating Leases [Text Block]
Commitments and Contingencies.
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Segment Information
Segment Reporting Disclosure [Text Block]
Segment Information
Subsequent Event
Subsequent Event
Subsequent Events [Text Block]
Insider Trading Arrangements [Line Items]
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
All Trading Arrangements [Member]
Individual [Axis]
All Individuals [Member]
Trading Arrangement, Securities Aggregate Available Amount
Trading Arrangement Duration
Trading Arrangement Expiration Date
Trading Arrangement Termination Date
Rule 10b5-1 Arrangement Adopted [Flag]
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Rule 10b5-1 Arrangement Terminated [Flag]
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Trading Arrangement Adoption Date
Trading Arrangement, Individual Title
Trading Arrangement, Individual Name
Material Terms of Trading Arrangement [Text Block]
Basis of Presentation
Principles of Consolidation
Use of estimates
Operating Segments
Significant Accounting Policies
The element represents significant accounting policies policy text block.
Recently Issued Accounting Pronouncements
The following table summarizes assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):
Schedule of Money Market Funds at their Level within the Fair Value Hierarchy
Property and equipment, net consisted of the following (in thousands):
A summary of stock option activity is presented below (in thousands, except per share and contractual life data).
A summary of restricted stock activity and related information (in thousands, except per share data):
The following table summarizes total stock-based compensation expense for stock options and RSUs, which is included in the statements of operations (in thousands):
Summary of Option Grant using the Black-Scholes Option-pricing Model
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of restricted stock units, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
Summary of Restricted Stock Units Grant using the Monte Carlo Simulation model
Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions [Table Text Block]
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):
The following table summarizes supplemental balance sheet information related to the Company’s operating leases (in thousands):
Other information related to leases are as follows (in thousands):
Schedule of segment reporting information, by segment
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of Organization, Consolidation and Presentation of Financial Statements [Table]
Consolidated Entities [Axis]
Consolidated Entities [Domain]
Cortigent, Inc. [Member]
Cortigent, Inc. [Member]
This member stands for the information pertaining to "Cortigent, Inc.".
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Promissory note [Member]
Notes Payable, Other Payables [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
The element represents securities purchase agreement.
Securities Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Sales Agreement [Member]
This member stands for the information pertaining to "Sales Agreement".
Sales Agreement [Member]
Class of Warrant or Right [Axis]
Class Of Warrant Or Right [Domain]
Warrant [Member]
Warrant [Member]
Counterparty Name [Axis]
Counterparty Name [Domain]
Jefferies LLC [Member]
Jefferies LLC (“Jefferies”) [Member]
This member stands for the information pertaining to "Jefferies LLC (“Jefferies”)".
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum [Member]
Minimum [Member]
Title and Position [Axis]
Title and Position [Domain]
Director [Member]
This member stands for the information pertaining to "Independent Director, One".
Independent Director, One [Member]
Independent Director, One [Member]
Chief Financial Officer [Member]
Geographical [Axis]
Geographical [Domain]
AUSTRALIA
Sale of Stock [Axis]
Sale of Stock [Domain]
Private Placement [Member]
Disclosure of Organization, Consolidation and Presentation of Financial Statements [Line Items]
Organization and Business Operations
Shares, Issued
Proceeds from Issuance of Common Stock and Warrants in Connection with At-Market offering, Gross
The gross proceeds of cash inflow from issuance of common stock and warrants in connection with at-the-market offering, during the reporting period.
Gross proceeds
The cash inflow from the issuance of common stock and warrants in connection with At-the-Market offering, net of issuance costs during the reporting period.
Issuance of common stock and warrants in connection with the Sales Agreement, net of issuance costs
Proceeds from Issuance of Common Stock and Warrants in Connection with At-Market offering, Net of Issuance Costs
Sales Of Common Stock Number Of Shares Issued In Connection With Private Sale
Sales of common stock in connection with private sale
The number of shares issued or sold in connection with private sale.
Common share price
Share price
Gross proceeds from the private sale transaction
Proceeds from Issuance of Private Placement
Common Stock, Par or Stated Value Per Share
Common stock, par value (in dollars per share)
Debt instrument, principal amount
Debt instrument, face amount
Debt Instrument, Face Amount
Number of securities called by warrants
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Number of warrants convertible
Share price (in dollars per share)
Share price (in dollars per share)
Weighted Average Exercise Price Per Share, Warrants outstanding at beginning balance
Weighted Average Exercise Price Per Share, Warrants outstanding at ending balance
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price per share
Warrants and Rights Outstanding, Term
Warrant term
Aggregate offering price
Sale of Common Stock At-Market offering, Authorized, Amount
The amount authorized for sale of common shares in connection with at-the-market offering.
Proceeds from Issuance of Common Stock and Warrants in Connection with Securities Purchase Agreement, Gross
The gross proceeds of cash inflow from issuance of common stock and warrants in connection with securities purchase agreement during the reporting period.
Gross proceeds
Number of equity purchase agreements
The number of equity purchase agreements by the reporting entity.
Number of equity purchase agreements
Committed capital
The amount of funds committed to the investors from the reporting entity.
Committed capital
Number of operating segments
Concentration Risk [Table]
SWITZERLAND
Fair Value, Recurring and Nonrecurring [Table]
Cash and Cash Equivalents [Axis]
Certificates of Deposit [Member]
Money Market Funds [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds
Short-Term Debt [Table]
Short-Term Debt, Type [Axis]
Short-Term Debt, Type [Domain]
Loans Payable [Member]
Short-Term Debt [Line Items]
Debt instrument, interest rate
Short-Term Debt, Percentage Bearing Fixed Interest Rate
Number of periodic payments
The number of periodic payments of debt instrument under the debt agreement.
Number of Periodic Payments
Debt Instrument, Frequency of Periodic Payment
Debt Instrument, Periodic Payment
Debt instrument, outstanding amount
Short-Term Debt
Property, Plant and Equipment [Table]
Long-Lived Tangible Asset [Axis]
Property Plant And Equipment [Domain]
Equipment [Member]
Furniture and Fixtures [Member]
Software and Software Development Costs [Member]
Computer Software [Member]
Construction in Progress [Member]
Construction in progress [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment
Property and equipment, gross
Contract Liabilities Other
Contract liabilities
The element represents contract liabilities other.
Stock, Class of Stock [Table]
Maxim Group LLC [Member]
Maxim Group LLC (“Maxim”) [Member]
This member stands for the information pertaining to "Maxim Group LLC (“Maxim”)".
Entity Affiliated With Director [Member]
This member stands for the information pertaining to "EAffiliated With Director".
Entity Affiliated With Directors [Member]
Entity Affiliated With Director And Investor [Member]
Entity Affiliated With Directors And Investor [Member]
This member stands for the information pertaining to "Entity Affiliated With Directors And Investor".
Placement Agency Agreement [Member]
Placement Agency Agreement [Member]
This member stands for information pertaining to "Placement Agency Agreement".
Think Equity LLC [Member]
Think Equity Llc [Member]
This member stands for the information pertaining to "ThinkEquity LLC".
Maximum [Member]
Maximum [Member]
Equity Securities
Class of Stock [Line Items]
Preferred stock, shares issued
Percentage of the aggregate proceeds raised from the sale of securities for cash fee payment to placement agency
The percentage of the aggregate proceeds raised from the sale of securities for cash fee payment to placement agency under agreement.
Percentage of Aggregate Proceeds Raised from Sale of Securities for Cash Fee Payment to Placement Agency
Legal Fees
Legal expenses, maximum payment under agreement
Securities Purchased under Agreements to Resell, Setoff Rights, Description
Description of purchase agreement
Per share amount received in connection with private Sale.
Sales of common stock in connection with private sale, price per share
Sales Of Common Stock In Connection With Private Sale Price Per Share
Proceeds from sales of common stock in connection with private sale, gross
Proceeds From Sales Of Common Stock In Connection With Private Sale Gross
The gross proceeds of cash inflow from the issuance of common stock in connection with private securities purchase agreement during the reporting period.
Number Of Tranche
Number of tranche
Represents the number of tranche.
Sale of common stock authorized in direct offering
Sale Of Common Stock At Direct Offering Authorized Shares
Number of shares of common stock authorized to sale in dirrect offering.
Proceeds from issuance of common stock in connection with direct offering gross
Proceeds From Issuance Of Common Stock In Connection With Direct Offering Gross
The cash inflow from the issuance of common stock in connection with direct offering gross during the reporting period.
Proceeds from Issuance of Common Stock in Connection with Direct Offering Net
Proceeds from issuance of common stock in connection with direct offering net
The cash inflow from the issuance of common stock in connection with direct offering, net during the reporting period.
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Number of Shares, Warrants outstanding at beginning balance
Number of Shares, Warrants outstanding at ending balance
Class of Warrant or Right, Outstanding
Outstanding warrants
Class of Warrant or Right, Grants in Period
Number of Shares, Issued
The number of share warrants granted during the period.
The number of share warrants exercised during the period.
Number of Shares, Exercised
Class of Warrant or Right, Exercises in Period
The number of shares under warrants that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the warrants agreement or that expired.
Number of Shares, Forfeited or expired
Class of Warrant or Right, Forfeitures and Expirations in Period
Class of Warrant or Right, Exercisable, Number
Number of Shares, Warrants exercisable at ending balance
The number of share warrants exercisable that may be converted into shares under warrants agreement.
The weighted average price per share amount at which grantees can acquire shares of common stock by exercise of warrants.
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price
Weighted Average Exercise Price Per Share, Issued
The weighted average price per share amount at which warrant holders acquired shares when converting their share warrants into shares.
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price
Weighted Average Exercise Price Per Share, Exercised
Class of Warrant or Right, Forfeitures and Expirations, Weighted Average Exercise Price
The weighted average price per share amount of warrants that were either forfeited or expired.
Weighted Average Exercise Price Per Share, Forfeited or expired
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the warrants plan.
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price
Weighted Average Exercise Price Per Share, Warrants exercisable at ending balance
The weighted average remaining contractual term for warrants outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted Average Remaining Contractual Life, Warrants outstanding at beginning balance (in Years)
Weighted Average Remaining Contractual Life, Warrants outstanding at ending balance (in Years)
Class of Warrant or Right, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Life, Warrants exercisable at ending balance (in Years)
The weighted average remaining contractual term for warrants exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Class of Warrant or Right, Exercisable, Weighted Average Remaining Contractual Term
The element represents right offering member.
Right Offering [Member]
Nano Precision Medical, Inc., Warrant [Member]
Nano Precision Medical, Inc., Warrant [Member]
This member stands for the information pertaining to "Nano Precision Medical, Inc., Warrant".
Second Sight Warrant Member
The element represents second sight warrant member.
Second Sight Warrant [Member]
The element represents class of warrants or rights term.
Term of warrants
Number of securities called by each warrant
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Class of Warrant or Right, Outstanding, Intrinsic Value
Warrants outstanding, intrinsic value
The amount by which the current fair value of the underlying stock exceeds the exercise price of warrants outstanding.
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Award Type [Axis]
All Award Types
Award Type [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Options outstanding at ending, number of shares (in shares)
Options outstanding at beginning, number of shares (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Options outstanding at ending, vested and expected to vest (in dollars per share)
Options outstanding at beginning, weighted average exercise price (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Granted
Granted, weighted average exercise price (in dollars per share)
Granted, weighted average exercise price (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Exercised
Exercised, weighted average exercise price (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Forfeited or expired
Forfeited or expired, weighted average exercise price (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Options exercisable, number of shares (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Options exercisable, weighted average exercise price (in dollars per share)
Options exercisable period (in years)
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Outstanding at ending, weighted average grant date fair value (in dollars per share)
Outstanding at beginning, weighted average grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Outstanding at ending, number of shares (in shares)
Outstanding at beginning, number of shares (in shares)
RSUs Granted
Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted
Vested and released
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested and released
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statement of Income Location, Balance [Axis]
Statement of Income Location, Balance [Domain]
Research and Development Expense [Member]
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense recognized
Allocated share-based compensation expense
Valuation date stock price
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share
Risk-free interest rate
Expected dividend yield
Expected volatility
Expected term
Plan Name [Axis]
Plan Name [Domain]
The element represents equity incentive plans member.
Equity Incentive Plans [Member]
Equity Incentive Plans [Member]
Stock Options (Market Conditions Vesting)
Stock Options with Market Conditions Vesting [Member]
This member stands for the information pertaining to "Stock Options with Market Conditions Vesting".
Issuance shares of common stock
Issuance shares of common stock
Common Stock, Capital Shares Reserved for Future Issuance
Common stock, shares available for future issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Share-based payment award, award vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Share-based payment award, award expiration period
Stock options exercisable
Estimated aggregate intrinsic value of stock options exercisable
The share price of the entity's common stock which would be required to be attained for the performance vesting criteria, based on market conditions in share-based payment arrangement.
Share-based payment award, performance vesting criteria, stock price trigger
Share-Based Payment Award, Performance Vesting Criteria, Stock Price Trigger
The threshold period of specified consecutive trading days within which common stock price would be required to be attained for the performance vesting criteria, based on market conditions in share-based payment arrangement.
Share-based payment award, performance vesting criteria, threshold consecutive trading days
Share-Based Payment Award, Performance Vesting Criteria, Threshold Consecutive Trading Days
The percentage of award shall vest on hurdle achievement date subject to achievement of performance condition in share-based payment arrangement.
Percentage of award shall vest on hurdle achievement date subject to achievement of performance condition
Share-Based Payment Award, Percentage of Award Shall Vest on Hurdle Achievement Date Subject to Achievement of Performance Condition
The percentage of award shall vest first anniversary after hurdle achievement date subject to achievement of performance condition in share-based payment arrangement.
Percentage of award shall vest first anniversary after hurdle achievement date subject to achievement of performance condition
Share-Based Payment Award, Percentage of Award Shall Vest First Anniversary after Hurdle Achievement Date Subject to Achievement of Performance Condition
The percentage of award shall vest second anniversary after hurdle achievement date subject to achievement of performance condition in share-based payment arrangement.
Percentage of award shall vest second anniversary after hurdle achievement date subject to achievement of performance condition
Share-Based Payment Award, Percentage of Award Shall Vest Second Anniversary after Hurdle Achievement Date Subject to Achievement of Performance Condition
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation cost
Weighted average period (in years)
Weighted average period (in years)
The weighted average grant-date fair value of share-based payment awards granted during the reporting period as calculated by applying the disclosed pricing methodology upon fair value assumptions.
Share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average grant date fair value
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Subsequent to Performance Period End Date
Share-based payment award, award vesting period
The subsequent period to performance period end date over which grantee's right to exercise award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Share-based payment award, award vesting period subsequent to performance period end date
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments
Share-based payment award, fair value assumptions, expected dividend payments
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Including Subsequent Period to Performance Period End Date
Share-based payment award, award vesting period including subsequent period to performance period end date
The award vesting period including subsequent period to performance period end date over which grantee's right to exercise award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
The specified period per year for forecasted common stock price using the valuation assumptions in share-based payment arrangement.
Share-based payment award, forecasted stock price, specified period per year
Share-Based Payment Award, Forecasted Stock Price, Specified Period Per Year
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities [Axis]
Antidilutive Securities [Domain]
Stock Options [Member]
The element represents stock options.
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Total
Liabilities, other than long-term debt, noncurrent
Right-of-use Assets And Operating Lease Liabilities
Leases [Abstract]
Thereafter
Lessee, Operating Lease, Liability, to be Paid, after Year Five
Total lease payments
Lessee, Operating Lease, Liability, to be Paid
Total lease liabilities
Operating Lease, Liability
Weighted average discount rate
Weighted average remaining lease term
Cash paid for operating lease liabilities
The element represents cash paid for operating lease liabilities.
Right of Use Assets and Operating Lease Liabilities [Table]
Disclosure of information about right-of-use assets and operating lease liabilities.
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Lease Contractual Term [Axis]
Lease Contractual Term [Domain]
Alameda CA [ Member]
Valencia CA [Member]
Lessor [Member]
The element represents lessor member.
Sublease Storage Space [Member]
Sublease For Manufacturing Facility [Member]
This member stands for the information pertaining to "Sublease For Manufacturing Facility ".
Sublease For Manufacturing Facility [Member]
Right of Use Assets and Operating Lease Liabilities [Line Items]
The maximum period for lease term which are not recorded on the balance sheet, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Maximum Period for Lease Term Which are Not Recorded on Balance Sheet
Lease term which are not recorded on the balance sheet
Area of building property
Area of Real Estate Property
Lease terminates
Net lease agreement description
Lease agreement, effective date
The element represent lease effective date.
Office space rental related expenses
Rental payments
Description of lease
Description of sub lease terms
Operating lease cost
Operating lease maintenance charges
Lease Expiration Date
Lessor, Operating Lease, Term of Contract
Clinical and regulatory expense
The element represents clinical and regulatory expense.
Liquidated damages
The element represents liquidated damages paid value.
Description of contract termination and claims
Loss contingency, damages paid, value
Demanded damages, value
Description of legal settlement
Loss Contingency, Loss in Period
Charge related to legal settelment
Schedule of Segment Reporting Information, by Segment [Table]
Segments [Axis]
Segments [Domain]
Biopharm Division [Member]
The element represents biopharm division member.
Neuromodulation Division [Member]
The element represents neuromodulation division member.
Segment Reporting Information [Line Items]
Number of Reportable Segments
Number of reporting segments
Personnel and related expenses
Labor and Related Expense
The amount of expense arising from the development related activity of reporting entity.
Development expenses
Development Expense
The amount of expense related to payments for professional services and insurance related expenses.
Professional services and insurance
Professional Services and Insurance Expense
Other General and Administrative Expense
Other general and administrative expenses
Other Nonoperating Income (Expense)
Other income (expense), net
Subsequent Event [Table]
Subsequent Event [Line Items]
Expected Proceeds From Sales Of Common Stock In Connection With Private Sale Gross
The expected gross proceeds of cash inflow from the issuance of common stock in connection with private sale during the reporting period.
Expected proceeds from sales of common stock in connection with private sale, gross
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted-average grant-date fair value of options granted
SPIC insured amount
The element represents cash spic insured amount.
SPIC cash limit coverage
The element represents spic cash limit coverage.
Cash, FDIC Insured Amount
FDIC insured amount
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Summary of Warrant Activity
Stock Options With Service Vesting [Member]
Stock Options With Service Vesting [Member]
his member stands for the information pertaining to stock options with service vesting.
Receivables, Net, Current
Receivables
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Option [Member]
Stock Options [Member]
Sale of Common Stock at Direct Offering Price Per Share
Sale of common stock at direct offering price per share
Sale of common stock at direct offering price per share.
License and Supply Agreement [Member]
License and Supply Agreement [Member]
This member stands for information pertaining to "License and Supply Agreement".
Okava Pharmaceuticals Inc [Member]
Okava Pharmaceuticals, Inc. [Member]
This member stands for information pertaining to "Okava Pharmaceuticals, Inc.".
Number of Tranche Closed
Number of tranche closed
Represents the number of tranche.
Net cash provided by (used in) financing activities
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net increase (decrease) in cash, cash equivalents and restricted cash
Proceeds from Issuance of Common Stock in Connection with at Market Offering Net of Issuance Costs
Net issuance costs in connection with the Sales Agreement
The cash inflow from the issuance of common stock in connection with At-the-Market offering, net of issuance costs during the reporting period.
Issuance of common stock and warrants in connection with the Sales Agreement, net of issuance costs
Stock issuance costs
Payments of Stock Issuance Costs
Net issuance costs in connection with the Sales Agreement
Proceeds From Issuance Of Common Stock In Connection With Direct Offering Net Of Issuance Expense
Proceeds from issuance of common stock in connection with direct offering net of issuance expense
The cash inflow from the issuance of common stock in connection with direct offering net of issuance expense during the reporting period.
Issuance Of Common Stock In Connection With Direct Offering Issuance Expense
Issuance of common stock in connection with direct offering, issuance expense
Amount of issuance expense in connection with issuance of common stock in direct offering.
Stock Issued During Period Value Issuance Of Common Stock In Connection With Private Placement
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs
The value of stock issued during the period upon issuance of common stock in connection with private placement.
Stock Issued During Period Shares Issuance Of Common Stock In Connection With Private Placement
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs (in shares)
The number of shares issued during the period upon issuance of common stock in connection with private placement.
Stock Issued During Period Value Issuance Of Common Stock In Connection With Registered Direct Offering Net Of Issuance Costs
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs
The value of stock issued during the period upon issuance of common stock in connection with registered direct offering, net of issuance costs.
Stock Issued During Period Shares Issuance Of Common Stock In Connection With Registered Direct Offering Net Of Issuance Costs
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs (in shares)
The number of shares issued during the period upon issuance of common stock in connection with registered direct offering, net of issuance costs.
Stockholders’ equity:
STOCKHOLDERS' EQUITY:
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated depreciation
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited and expired
The following table summarizes a maturity analysis of our lease liabilities showing the aggregate lease payments as of June 30, 2026 (in thousands except weighted average data):
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2026 (remaining)
Options outstanding at ending, vested and expected to vest (in years)
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares
Business combination, consideration receivable in tems of shares
Business Combination, Recognized Liability Assumed, Long-Term Debt, Noncurrent
Business combination, financing raised
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Forfeited and expired
Business Combination [Axis]
Business Combination [Domain]
ClearOne Inc [Member]
ClearOne, Inc. [Member]
This member stands for information pertaining to "CleareOne, Inc."
Neurostimulation Division [Member]
Neurostimulation Division [Member]
The element represents neurostimulation division member.
Computer Equipment [Member]
Computer Hardware [Member]
Depreciation
Depreciation
Contract Liabilities Write Off
Contract liabilities write off
Amount of contract liabilities write off.
Proceeds from Issuance of Common Stock in Connection With Private Purchase Net of Issuance Costs
Issuance of common stock to related party in connection with 2025 Private Sales Transactions, net
The cash inflow from the issuance of common stock in connection with private purchase, net of issuance costs during the reporting period.
Stock Issued During Period Value Issuance Of Common Stock In Connection With Private Purchase Net Of Issuance Costs
Issuance of common stock to related party in connection with 2025 Private Sales Transactions
The value of stock issued during the period upon issuance of common stock in connection with private purchase, net of issuance costs.
Stock Issued During Period Shares Issuance Of Common Stock In Connection With Private Purchase Net Of Issuance Costs
Issuance of common stock to related party in connection with 2025 Private Sales Transactions (in shares)
The number of shares issued during the period upon issuance of common stock in connection with private purchase, net of issuance costs.
Operating expenses
Total operating expenses
Weighted average shares outstanding - basic (in shares)
Weighted average shares
Weighted average shares outstanding - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
During the three and six months ended June 30, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted net loss per share because including them would have been antidilutive (in thousands).
Stock Issued During Period, Value, Issuance of Common Stock and Warrants in Connection with At-Market Offering, Net of Issuance Costs
Issuance of common stock in connection with the Sales Agreement, net of issuance costs
The value of stock issued during the period upon issuance of common stock and warrants in connection with at-the-market offering, net of issuance costs.
Stock Issued During Period, Shares, Issuance of Common Stock and Warrants in Connection with At-Market Offering, Net of Issuance Costs
Issuance of common stock in connection with the Sales Agreement, net of issuance costs (in shares)
The number of shares issued during the period upon issuance of common stock and warrants in connection with at-the-market offering, net of issuance costs.
Adjustments to Additional Paid-in-Capital Common Stock and Warrants Issued in Connection With-at-Market Offering Issuance Costs
The amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing common stock and warrants in connection with at-the-market offering. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.
Issuance of common stock in connection with the Sales Agreement, net of issuance costs
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Other comprehensive loss
Other comprehensive income:
Proceeds from Issuance of Common Stock in Connection With Registered Direct Offering Net of Issuance Costs
Issuance of common stock in connection with 2026 Registered Direct Offering, net
The cash inflow from the issuance of common stock in connection with registered direct offering, net of issuance costs during the reporting period.
Proceeds from Issuance of Common Stock in Connection With Private Placement Net of Issuance Costs
Issuance of common stock to related party in connection with 2026 Private Placement, net
The cash inflow from the issuance of common stock in connection with private placement, net of issuance costs during the reporting period.
Common Stock, Value, Issued
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 89,410 and 76,428 at June 30, 2026 and December 31, 2025, respectively
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from research and development tax incentive receivables.
R&D tax credit incentive receivable
Increase (Decrease) in Research and Development Tax Incentive Receivable
Gain On Derecognition Of Contract Liabilities
Amount of gain on derecognition of contract liabilities.
Gain on derecognition of contract liabilities
Gain on derecognition of contract liabilities
Adjustment For Gain On Derecognition Of Contract Liabilities
Amount of adjustment for gain on derecognition of contract liabilities.
Gain on derecognition of contract liabilities